Ligand profile
W8S
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_32123 — chaperone protein HtpG
Identifiers
Database identifiers and provenance.
- Ligand ID
W8S- PDB
7k9w- UniProt (similar protein)
J9VVA4- Target protein
- KP13_32123
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 99.9
- −1 ≤ LogP ≤ 5 4.41
- MW ≤ 500 Da 456.5
- LogP ≤ 5 4.41
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 99.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cn1c(cc(n1)c2cccc(c2)OC)Nc3cc(cc(c3C(=O)N4Cc5ccccc5C4)O)OCn1c(cc(n1)c2cccc(c2)OC)Nc3cc(cc(c3C(=O)N4Cc5ccccc5C4)O)O
InChI=1S/C26H24N4O4/c1-29-24(13-21(28-29)16-8-5-9-20(10-16)34-2)27-22-11-19(31)12-23(32)25(22)26(33)30-14-17-6-3-4-7-18(17)15-30/h3-13,27,31-32H,14-15H2,1-2H3InChI=1S/C26H24N4O4/c1-29-24(13-21(28-29)16-8-5-9-20(10-16)34-2)27-22-11-19(31)12-23(32)25(22)26(33)30-14-17-6-3-4-7-18(17)15-30/h3-13,27,31-32H,14-15H2,1-2H3
ZXMXRXCCHDGDFA-UHFFFAOYSA-NZXMXRXCCHDGDFA-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF13589
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand W8S →
- PDB RCSB structure 7k9w →
- UniProt UniProt J9VVA4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “W8S”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_32123.
PDB 27
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 6
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).